ReviewArchives of microbiology2026
Probiotic microcapsule polysaccharide-protein composite system: construction, mechanism and application.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Microencapsulation technology can effectively protect the activity of endogenous probiotics, extend the shelf life of probiotics, and achieve their targeted release in vitro. Therefore, it has been widely used in the field of food processing. However, the complex food environment requires careful selection of microcapsule synthesis methods and materials. Polysaccharide-protein composite microcapsules represent a popular strategy for probiotic protection. However, most existing studies evaluate the protective performance of carriers based on simplified in vitro models, and experimental conclusions are highly condition dependent. There is a lack of horizontal trade-off comparisons regarding the advantages and drawbacks of different carriers, and substantial gaps remain in translating laboratory systems to real food and in vivo environments. In this paper, five types of typical polysaccharide-protein composite carriers are selected to systematically summarize the molecular interaction mechanisms and encapsulation processes, and to critically analyze the applicable scenarios, inherent shortcomings of each system and limitations of existing research. The study reveals that raw material batch variation, difficulties in large-scale preparation, and insufficient evidence of in vivo effects are the core bottlenecks restricting the commercialization of this technology. This paper summarizes the mechanistic controversies and industrialization barriers of polysaccharide-protein probiotic microcapsules, aiming to provide references for the targeted design of subsequent probiotic delivery carriers and the establishment of evaluation systems.
Indexed as
Identifiers
42878860What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.